Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Myopia Control With a Innovative Spectacle Lens - A Cessation Study

NCT: NCT06884527 · ACTIVE_NOT_RECRUITING

NCT IDNCT06884527
StatusACTIVE_NOT_RECRUITING
Start Date2025-02-18
SponsorEssilor International (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑